A pregnancy can sometimes seem completely normal right up to delivery, only for unexpected symptoms like bruising or bleeding in a newborn to occur, raising concerns of fetal and neonatal alloimmune thrombocytopenia (FNAITFetal and neonatal alloimmune thrombocytopenia A rare condition in which a mother’s immune system attacks fetal platelets, leading to dangerously low platelet levels before and/or after birth.).
While rare, the condition, in which a mother’s immune system targets the baby’s platelets, can cause bleeding complications and can even be life-threatening.
Because many women often experience no FNAIT symptoms during pregnancy, a patient’s medical and pregnancy history can contain important early warning signs.
Why FNAIT happens
FNAIT occurs when a pregnant woman who lacks a specific platelet antigen carries a fetus that has inherited that antigen from the other parent. The mother’s immune system may recognize the fetal platelets as foreign and produce antibodies against them.
Learn more about FNAIT causes and risk factors
These antibodies can cross the placenta and destroy fetal platelets, sometimes leading to severe bleeding complications, including intracranial hemorrhageBrain bleed Bleeding inside the fetal brain, also known as an intracranial hemorrhage. In FNAIT, it's often caused by severe thrombocytopenia and can lead to long-term disability or death. in newborns.
How past pregnancies offer clues
If a woman had one pregnancy affected by FNAIT, there’s a 90% chance future pregnancies will also be affected. But even if there was no FNAIT diagnosis in a prior pregnancy, there may still be subtle clues.
If a newborn has unexplained bruising, low platelet counts or bleeding shortly after delivery, this may indicate the condition was present but undiagnosed. This can occur because physicians may not recognize signs due to the condition’s rarity, or they may attribute subtle symptoms like mild bruising to the trauma of childbirth.
In some families, prior miscarriages without a clear cause may also be relevant, as this could signal the presence of circulating platelet alloantibodies. These patterns can help clinicians suspect immune-related platelet destruction in a subsequent pregnancy and prompt further testing or monitoring earlier in care.
Why maternal history matters
Because antibody levels can increase with each pregnancy, FNAIT often becomes more severe in subsequent pregnancies. Patients who have had a previous pregnancy affected by FNAIT should be treated with intravenous immunoglobulin (IVIG) starting at around month three or four of the pregnancy.
If a family isn’t aware that a prior baby may have been affected, they may miss the opportunity for early monitoring and intervention. Careful review of maternal history can reveal patterns that identify risk early, allowing doctors to plan care, reduce complications and improve outcomes for newborns who might otherwise face serious bleeding risks.
Sign up here to get the latest news, perspectives, and information about FNAIT sent directly to your inbox. Registration is free and only takes a minute.
